학술논문
A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study
Document Type
Article
Author
Source
In Gynecologic Oncology September 2015 138(3):507-512
Subject
Language
ISSN
0090-8258